Skip to main content
. Author manuscript; available in PMC: 2020 Oct 30.
Published in final edited form as: Processes (Basel). 2016 Oct 18;4(4):38. doi: 10.3390/pr4040038

Figure 6.

Figure 6.

Simulated endotoxemia with MPC of HA device B (blue) or null treatment (red). MPC with device B, which captures both cytokines and WBC, is able to guide the inflammatory state to the reference trajectory. Endotoxin dose was 12 mg/kg and HA intervention began immediately at t = 0.